Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $35,100 | 12 | 36.0% |
| Food and Beverage | $32,264 | 1,138 | 33.1% |
| Travel and Lodging | $17,916 | 75 | 18.4% |
| Consulting Fee | $12,125 | 10 | 12.4% |
| Education | $6.97 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $23,080 | 184 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $19,362 | 59 | $0 (2024) |
| Medtronic Vascular, Inc. | $18,274 | 268 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $10,542 | 33 | $0 (2022) |
| PFIZER INC. | $9,772 | 80 | $0 (2024) |
| Boston Scientific Corporation | $4,595 | 68 | $0 (2024) |
| Abbott Laboratories | $3,647 | 116 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $2,170 | 124 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $648.52 | 91 | $0 (2024) |
| Impulse Dynamics (USA) Inc. | $535.76 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $9,027 | 129 | Medtronic, Inc. ($6,781) |
| 2023 | $12,399 | 162 | Medtronic, Inc. ($8,383) |
| 2022 | $10,624 | 129 | Medtronic, Inc. ($5,110) |
| 2021 | $4,395 | 83 | Medtronic, Inc. ($2,806) |
| 2020 | $1,328 | 42 | Medtronic Vascular, Inc. ($762.19) |
| 2019 | $10,908 | 183 | E.R. Squibb & Sons, L.L.C. ($5,955) |
| 2018 | $15,275 | 201 | Medtronic Vascular, Inc. ($7,309) |
| 2017 | $33,457 | 307 | Janssen Pharmaceuticals, Inc ($10,407) |
All Payment Transactions
1,236 individual payment records from CMS Open Payments — Page 1 of 50
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.76 | General |
| Category: Cardiovascular | ||||||
| 12/20/2024 | Medtronic, Inc. | PULSESELECT (Device) | Food and Beverage | In-kind items and services | $40.92 | General |
| Category: Ablation | ||||||
| 12/19/2024 | Medtronic, Inc. | — | Travel and Lodging | In-kind items and services | $543.87 | General |
| 12/18/2024 | Medtronic, Inc. | PULSESELECT (Device) | Food and Beverage | In-kind items and services | $28.57 | General |
| Category: Ablation | ||||||
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $21.94 | General |
| Category: Cardiovascular | ||||||
| 12/10/2024 | Abbott Laboratories | ENSITE (Device) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: Electrophysiology | ||||||
| 12/10/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Obesity | ||||||
| 12/10/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $8.58 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/18/2024 | Medtronic, Inc. | PULSESELECT (Device) | Food and Beverage | In-kind items and services | $6.61 | General |
| Category: Ablation | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $8.00 | General |
| Category: Cardiovascular | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/11/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $32.72 | General |
| Category: Cardiovascular | ||||||
| 11/07/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/01/2024 | Medtronic, Inc. | ACHIEVE (Device) | Food and Beverage | In-kind items and services | $5.77 | General |
| Category: Catheters | ||||||
| 10/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: DIABETES | ||||||
| 10/29/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.75 | General |
| Category: Cardiovascular | ||||||
| 10/22/2024 | Baxter Healthcare | Hillrom - Cardiac Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 10/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $10.96 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $6.95 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/03/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/30/2024 | Medtronic, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,100.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 62 | 6,997 | 10,907 | $2.1M | $513,446 |
| 2022 | 60 | 7,377 | 12,350 | $2.2M | $538,943 |
| 2021 | 57 | 7,982 | 13,557 | $2.1M | $549,424 |
| 2020 | 60 | 8,052 | 13,583 | $2.1M | $531,811 |
All Medicare Procedures & Services
239 procedure records from CMS Medicare Utilization — Page 1 of 10
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 1,082 | 1,902 | $656,190 | $156,320 | 23.8% |
| 93656 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | Facility | 2023 | 87 | 87 | $249,690 | $59,777 | 23.9% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 218 | 529 | $38,088 | $24,617 | 64.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 169 | 192 | $83,172 | $23,993 | 28.8% |
| 33340 | Repair of left upper heart chamber with implant with review by radiologist | Facility | 2023 | 49 | 49 | $114,317 | $17,274 | 15.1% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 655 | 1,013 | $88,131 | $15,350 | 17.4% |
| 93655 | Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | Facility | 2023 | 59 | 59 | $58,115 | $13,242 | 22.8% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 415 | 620 | $50,220 | $13,125 | 26.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 77 | 77 | $44,067 | $11,376 | 25.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 756 | 1,184 | $71,040 | $11,358 | 16.0% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 245 | 398 | $64,078 | $10,331 | 16.1% |
| 93650 | Destruction of heart conduction tissue to create heart block | Facility | 2023 | 23 | 24 | $36,000 | $10,020 | 27.8% |
| 33249 | Insertion of implantable defibrillator system | Facility | 2023 | 15 | 15 | $34,920 | $9,798 | 28.1% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 257 | 486 | $36,450 | $8,905 | 24.4% |
| 33274 | Insertion of permanent leadless pacemaker using imaging guidance | Facility | 2023 | 32 | 33 | $42,933 | $8,691 | 20.2% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 264 | 301 | $28,595 | $7,433 | 26.0% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 20 | 20 | $26,800 | $7,136 | 26.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 53 | 54 | $26,915 | $6,855 | 25.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 79 | 116 | $22,504 | $6,766 | 30.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 60 | 60 | $26,940 | $6,679 | 24.8% |
| 33228 | Removal and replacement of dual lead permanent pacemaker | Facility | 2023 | 28 | 28 | $23,856 | $6,562 | 27.5% |
| 33225 | Insertion of left lower heart electrode for pacemaker or defibrillator | Facility | 2023 | 19 | 19 | $20,729 | $6,387 | 30.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 58 | 60 | $22,020 | $5,756 | 26.1% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 46 | 267 | $18,156 | $4,899 | 27.0% |
| 93284 | Programming of multiple lead implantable defibrillator system | Office | 2023 | 93 | 115 | $17,837 | $4,487 | 25.2% |
About Dr. Eric Johnson, MD
Dr. Eric Johnson, MD is a Clinical Cardiac Electrophysiology healthcare provider based in Memphis, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1447342811.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Johnson, MD has received a total of $97,413 in payments from pharmaceutical and medical device companies, with $9,027 received in 2024. These payments were reported across 1,236 transactions from 51 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($35,100).
As a Medicare-enrolled provider, Johnson has provided services to 30,408 Medicare beneficiaries, totaling 50,397 services with total Medicare billing of $2.1M. Data is available for 4 years (2020–2023), covering 239 distinct procedure/service records.
Practice Information
- Specialty Clinical Cardiac Electrophysiology
- Location Memphis, TN
- Active Since 09/29/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RC0001X
- Entity Type Individual
- NPI Number 1447342811
Products in Payments
- ELIQUIS (Drug) $28,379
- XARELTO (Drug) $10,533
- Arctic Front (Device) $3,393
- Micra (Device) $2,319
- ENTRESTO (Drug) $1,945
- Claria MRI (Device) $1,670
- WATCHMAN (Device) $1,582
- EVERA MRI XT DR SURESCAN (Device) $1,362
- COBALT DR MRI SURESCAN (Device) $1,124
- MICRA (Device) $942.72
- SelectSecure (Device) $897.55
- ENSITE (Device) $754.53
- NA (Device) $751.71
- Evera (Device) $618.23
- TYRX (Device) $593.56
- Optimizer (Device) $482.88
- Azure (Device) $452.23
- PULSESELECT (Device) $429.95
- AVEIR (Device) $389.36
- PRADAXA (Drug) $382.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Clinical Cardiac Electrophysiology Doctors in Memphis
Mark Coppess, Md, MD
Clinical Cardiac Electrophysiology — Payments: $3,964
James Porterfield, M.d, M.D
Clinical Cardiac Electrophysiology — Payments: $1,924
Glenn Wetzel, Md, MD
Clinical Cardiac Electrophysiology — Payments: $1,219